Top compounds associated with response to DEFB134


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.02
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.16 0.03
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.1 0.03
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.087 0.03
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.078 0.03
mRNA XMD11-85h GDSC1000 pan-cancer AAC 0.11 0.03
mRNA fingolimod CTRPv2 pan-cancer AAC -0.08 0.03
mRNA CIL55A CTRPv2 pan-cancer AAC 0.13 0.03
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.03
mRNA MS-275 CTRPv2 pan-cancer AAC 0.071 0.03
Download CSV